Researchers Say LSD Analog Has Potential to Treat Schizophrenia – Ganjapreneur | Where to order Skittles Moonrock online
Learn how to order CBD Oil online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
š Click here to Visit our shop! š

Wed / Apr 16th
Researchers at UC Davis say they have developed an analog of LSD named JRT that encourages neuroplasticity without psychedelic side effects, and could be an effective treatment for schizophrenia.
Full story after the jump.
University of California, Davis researchers say they have developed a drug from LSD that promotes neuroplasticity and could be an effective schizophrenia treatment.
The researchers created the drug, called JRT, by switching two atoms in the molecular structure of LSD ā essentially āa tire rotation,ā according to co-author David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics and a professor of chemistry, biochemistry, and molecular medicine at UC Davis.
āBy just transposing two atoms in LSD, we significantly improved JRTās selectivity profile and reduced its hallucinogenic potential,ā Olson said in a UC Davis report. The result was a drug that encourages neural plasticity, which is the brainās ability to change and adapt through life experience, without any of the psychedelic side effects associated with LSD.
Crucially, the researchers found JRT did not promote gene expression commonly associated with schizophrenia, which can be amplified by the use of LSD.
āNo one really wants to give a hallucinogenic molecule like LSD to a patient with schizophrenia. The development of JRT emphasizes that we can use psychedelics like LSD as starting points to make better medicines. We may be able to create medications that can be used in patient populations where psychedelic use is precluded.ā ā Olson, in the report
The researchers also noted that JRT is an effective antidepressant that is about a hundred times more potent than ketamine.
The research was funded by grants from the National Institutes of health, the UC Davis Provostās Undergraduate Fellowship, the Camille and Henry Dreyfus Foundation, the Dr. Mohsen Najafi Research Award in Medicinal Chemistry, the Boone Family Foundation, Hope for Depression Research Foundation, the Pritzker Neuropsychiatric Disorders Research Consortium, the L.I.F.E. Foundation, the Chan-Zuckerberg Initiative Imaging Scientist Award, and a National Science Foundation NeuroNex Award.
Get daily cannabis business news updates. Subscribe
Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.
Ganjapreneur is made possible by our partners:
Latest Cannabis News
Cannabis Dispensary Sues State Over Labor Peace Agreement Rules in Adult-Use Law
Survey Finds Majority of Canadians View Cannabis as Important to Countryās Economy
Missouri Adds 6k Products to 2023 Product Recall
Tennessee House Passes Ban on Hemp Flower and THCA
Survey Finds Majority of Americans Believe Store-Bought Cannabis Contains Pesticides
Scotts Miracle-Gro Company Transfers Cannabis Investment Arm to āStrategic Partnerā
News by Market:
News by Topic:
- Stocks
- CBD
- Legalization
- Decriminalization
- Business
- Regulations
- Adult Use
- Medical Cannabis
- Social Equity
- Expungement
- Veterans
- Hemp Industry
- Events
- Politics
- Federal Policy
- Law Enforcement
- International
- Entrepreneurs
- Investing
- Licensing
- Banking
- Marketing
- Technology
- Celebrities
- Sports
- Popular Culture
- Normalization
- Extracts
- Edibles
- Lawsuits
Featured Business Profiles
From Our Partners
The Role of Terpenes in Blue Dream and Green Crack: What You Need to Know
DNA Genetics
Trends in Cannabis and Hemp Prerolls: Premium Options and Custom Formulas
HempNova
Top Shelf DNA Genetics Strains for Indoor Growing Success
DNA Genetics


Leave a Reply
Want to join the discussion?Feel free to contribute!